Warby Parker Inc.

NYSE:WRBY

Medical - Instruments & Supplies

Healthcare
$28.22 +3.78%

+$0.92 today

Market cap
$3.07B
Beta
1.97
P/E (TTM)
2305.1
EPS (TTM)
$0.01
52W Low $14.96High $31.00

Volume 5.90M

Average 2.81M

WRBY Other Income / Expenses

Net non-operating gains and losses, such as investment results, currency effects, and one-off items.

Warby Parker Inc.NYSE: WRBY

Other Income / Expenses · Q2 FY2026 · quarter ended Jun 2026

Other income / expenses growth accelerates

Q2 FY2026 other income / expenses of $2.08M rose 5.0% year over year, ahead of the -15.7% change in trailing-twelve-month other income / expenses. Sequentially, it fell 10.6% from the prior quarter. Over 3 fiscal years it compounded at +85.8% a year.

Context

  • Other income / expenses amounted to 1.0% of revenue in FY2025, down 0.4 pp from a year earlier.
  • Other income / expenses increased in 2 of the last 3 fiscal years.

What to watch

Whether quarterly growth of +5.0% holds above the trailing-twelve-month pace of -15.7%.

Sources:Income StatementText generated from reported figures; not investment advice.

Latest quarterJun 2026
$2.08M-10.6% QoQ
Last fiscal yearDec 2025
$8.38M-20.9% YoY
LTMJun 2026
$8.36M-15.7% YoY
Other Income / Expenses past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+5.0%——
1 year-20.9%——
3-year CAGR+85.8%——
5-year CAGR——
10-year CAGR——

Other Income / Expenses history

USD · from the income statement

Latest · FY2025
8.38M USD
Year-over-year change
-20.9%

Other Income / Expenses vs competitors

How WRBY compares with its peers on the latest reported figures

  • WRBY's LTM Jun 2026 other income / expenses of $8.36M is the 2nd highest of the 10 companies compared; the peer median is -$112.63M.
  • Its year-over-year change of -15.7% is the 5th highest of 10, against a peer median of -16.4%.
  • Other income / expenses amounts to 0.9% of revenue for WRBY, versus a peer median of 7.5%.
WRBY Competitors Peer median
Other Income / Expenses for WRBY and competitors
Company Period LTM YoY 3-year CAGR% of revenue
BEAMBeam Therapeutics Inc.LTM Jun 2026$292.6M +517.4%+79.2%187.5%
WRBYWarby Parker Inc.LTM Jun 2026$8.36M -15.7%+85.8%0.9%
LMATLeMaitre Vascular, Inc.LTM Mar 2026$7.55M +42.2%+122.4%2.9%
ITGRInteger Holdings CorporationLTM Jul 2026-$37.96M +63.6%—2.1%
CONConcentra Group Holdings Parent, Inc.LTM Sep 2026-$103.76M +5.5%—4.4%
ICUIICU Medical, Inc.LTM Jun 2026-$112.63M -110.5%—5.2%
HAEHaemonetics CorporationLTM Jun 2026-$115.31M -1983.3%—8.5%
QDELQuidelOrtho CorporationLTM Mar 2026-$199.2M -16.4%—7.5%
XRAYDENTSPLY SIRONA Inc.LTM Mar 2026-$788M -1112.3%—21.4%
BHCBausch Health Companies Inc.LTM Jun 2026-$3.49B -159.9%—32.2%
Peer median (excluding WRBY) -$112.63M-16.4%+100.8%7.5%

Competitors are the stored peer set for WRBY. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue540.8M598.11M669.77M771.32M871.91M
Cost of Revenue223.05M257.05M304.54M344.48M401.33M
Gross Profit317.75M341.06M365.22M426.83M470.58M
Gross Margin58.8%57.0%54.5%55.3%54.0%
Research & Development00000
Selling, General & Admin461.41M452.27M421.57M440.05M475.92M
Operating Expenses461.41M452.27M437.22M456.95M475.92M
Depreciation & Amortization21.87M31.86M38.55M45.87M50.28M
EBITDA(122.14M)(78.03M)(24.21M)26.35M53.32M
EBITDA Margin-22.6%-13.0%-3.6%3.4%6.1%
Operating Income(143.66M)(111.2M)(72M)(30.11M)(5.34M)
Operating Margin-26.6%-18.6%-10.7%-3.9%-0.6%
Interest Income01.31M9.23M10.6M8.38M
Interest Expense347K0000
Other Income / Expenses(347K)1.31M9.23M10.6M8.38M
Income Before Tax(144.01M)(109.9M)(62.76M)(19.52M)3.04M
Pre-Tax Margin-26.6%-18.4%-9.4%-2.5%0.3%
Income Tax Expense263K497K433K875K1.4M
Net Income(144.27M)(110.39M)(63.2M)(20.39M)1.64M
Net Margin-26.7%-18.5%-9.4%-2.6%0.2%
EPS (Basic)(1.39)(0.96)(0.54)(0.17)0.01
EPS (Diluted)(1.39)(0.96)(0.54)(0.17)0.01
Weighted Avg Shares113.62M114.94M117.39M120.39M122.67M
Weighted Avg Shares (Diluted)113.62M114.94M117.39M120.39M125.1M

Warby Parker Inc.

NYSE:WRBY

Intrinsic Alpha fair value

Locked

Current Price

$28.22

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.